Therefore, we explored the relationship between DC-SIGN promoter polymorphisms and susceptibility to NPC by determining DC-SIGN promoter sequence variation in a case-control study in Cantonese. The gene discussed is CD209; the disease is nasopharyngeal carcinoma.